MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
179
Unique beneficiaries
—
Total services
13,131
Distinct HCPCS
6
Medicare payment
$87K
PRESCRIBING · PART D · 2024
Total Rx claims
452
Beneficiaries
—
Total drug cost
$343K
Distinct drugs
17
Brand share
67.0%
Top prescribed drugs
Galcanezumab-Gnlm74 claims
Rimegepant Sulfate58 claims
Fremanezumab-Vfrm39 claims
Ubrogepant39 claims
Topiramate34 claims
QUALITY · MIPS · 2024
Final MIPS score
82.9
Quality
70.2
Cost
72.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.33%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE